Vaginal misoprostol versus intracervical Foley catheter for cervical ripening in postdate primigravid women: a randomized clinical trial

Table 2 Comparison of the main study variables between the misoprostol and FC groups

Variable	Misoprostol group (N = 60)	FC group (N = 60)	Total	P-value	OR	95% CI
NVD N (%)	44 (73.3)	51 (85.0)	95 (79.2)	0.116^a	0.49	0.19–1.21
C-section N (%)	16 (26.7)	9 (15.0)	25 (20.8)	0.116^a	2.06	0.83–5.12
Placental abruption N (%)	9 (15.0)	1 (1.7)	10 (8.3)	0.008^a	10.41	1.28–85.00
Uterine tachysystole N (%)	13 (21.7)	0 (0.0)	13 (10.8)	< 0.001^a	2.28	1.84–2.82
Meconium-stained AF N (%)	10 (16.7)	7 (11.7)	17 (14.2)	0.432^a	1.51	0.54–4.29
Oxytocin requirement N (%)	25 (41.7)	44 (73.3)	69 (57.5)	< 0.001^a	0.26	0.12–0.56
NICU admission N (%)	3 (5.0)	2 (3.3)	5 (4.2)	1.000^b	1.53	0.25–9.48
Labor duration (minutes) mean ± SD	1425.67 ± 69.98	2023.92 ± 201.57		0.001^c

Abbreviations: N number, SD standard deviation, OR odds ratio, CI confidence interval, NVD normal vaginal delivery, C-section Cesarean section, AF amniotic fluid, NICU neonatal intensive care unit
^aAnalyzed by Chi-squared test
^bAnalyzed by Fisher’s exact test
^cAnalyzed by Student’s t-test

ISSN: 1471-2393